Shuwen Biotech Announce CE Mark of qPCR Assay for ERBB2 Expression
SNN,
CercaTest ERBB2 Assay and MammaTyper® may serve as novel companion diagnostics for anti-HER2 therapies targeting HER2-low cancer.
CercaTest ERBB2 Assay and MammaTyper® may serve as novel companion diagnostics for anti-HER2 therapies targeting HER2-low cancer.
1. Fernandez et al., Examination of Low ERBB2 Protein Expression in Breast Cancer Tissue, JAMA Oncol.
CercaTest ERBB2 Assay and MammaTyper® may serve as novel companion diagnostics for anti-HER2 therapies targeting HER2-low cancer.